Effects of multiple-dose ponesimod, a selective S1P(1) receptor modulator, on lymphocyte subsets in healthy humans

Por Jurcevic, Stipo, Juif, Pierre-Eric, Hamid, Colleen, Greenlaw, Roseanna, D’Ambrosio, Daniele, Dingemanse, Jasper
Publicado no Drug Des Devel Ther (2016)

All-trans retinoic acid can antagonize osteoblastogenesis induced by different BMPs irrespective of their dimerization types and dose-efficiencies

Por Liu, Yi, Ma, Xiaoqing, Guo, Jing, Lin, Zhen, Zhou, Miao, Bi, Wenjuan, Liu, Jinsong, Wang, Jingxiao, Lu, Haiping, Wu, Gang
Publicado no Drug Des Devel Ther (2018)

Best tigecycline dosing for treatment of infections caused by multidrug-resistant pathogens in critically ill patients with different body weights

Por Ibrahim, Mohamed M, Abuelmatty, Abdulla M, Mohamed, Gehan H, Nasr, Mohsen A, Hussein, Amal K, Ebaed, Mohy El Deen, Sarhan, Hatem A
Publicado no Drug Des Devel Ther (2018)

Multiple-dose pharmacokinetics and pharmacodynamics of evogliptin (DA-1229), a novel dipeptidyl peptidase IV inhibitor, in healthy volunteers

Por Gu, Namyi, Park, Min Kyu, Kim, Tae-Eun, Bahng, Mi Young, Lim, Kyoung Soo, Cho, Sang-Heon, Yoon, Seo Hyun, Cho, Joo-Youn, Jang, In-Jin, Yu, Kyung-Sang
Publicado em 2014

Self-emulsifying drug delivery systems as a tool to improve solubility and bioavailability of resveratrol

Por Balata, Gehan F, Essa, Ebtessam A, Shamardl, Hanan A, Zaidan, Samira H, Abourehab, Mohammed AS
Publicado no Drug Des Devel Ther (2016)

dCK expression correlates with 5-fluorouracil efficacy and HuR cytoplasmic expression in pancreatic cancer: A dual-institutional follow-up with the RTOG 9704 trial

Por McAllister, Florencia, Pineda, Danielle M, Jimbo, Masaya, Lal, Shruti, Burkhart, Richard A, Moughan, Jennifer, Winter, Kathryn A, Abdelmohsen, Kotb, Gorospe, Myriam, de Jesus Acosta, Ana, Lankapalli, Rachana H, Winter, Jordan M, Yeo, Charles J, Witkiewicz, Agnieska K, Iacobuzio-Donahue, Christine A, Laheru, Daniel, Brody, Jonathan R
Publicado em 2014

Reducing the trigger dose of recombinant hCG in high-responder patients attending an assisted reproductive technology program: an observational study

Por Tiboni, Gian Mario, Colangelo, Enrica Concetta, Ponzano, Adalisa
Publicado no Drug Des Devel Ther (2016)

Development of small bisquaternary cholinesterase inhibitors as drugs for pre-treatment of nerve agent poisonings

Por Kuca, Kamil, Karasova, Jana Zdarova, Soukup, Ondrej, Kassa, Jiri, Novotna, Eva, Sepsova, Vendula, Horova, Anna, Pejchal, Jaroslav, Hrabinova, Martina, Vodakova, Eva, Jun, Daniel, Nepovimova, Eugenie, Valis, Martin, Musilek, Kamil
Publicado no Drug Des Devel Ther (2018)

Reference ranges for antiepileptic drugs revisited: a practical approach to establish national guidelines

Por Reimers, Arne, Berg, Jon Andsnes, Burns, Margrete Larsen, Brodtkorb, Eylert, Johannessen, Svein I, Johannessen Landmark, Cecilie
Publicado no Drug Des Devel Ther (2018)

Dose-dependent effects of cisplatin on the severity of testicular injury in Sprague Dawley rats: reactive oxygen species and endoplasmic reticulum stress

Por Soni, Kiran Kumar, Kim, Hye Kyung, Choi, Bo Ram, Karna, Keshab Kumar, You, Jae Hyung, Cha, Jai Seong, Shin, Yu Seob, Lee, Sung Won, Kim, Chul Young, Park, Jong Kwan
Publicado no Drug Des Devel Ther (2016)

The positive and negative effects of using transdermal nonsteroidal anti-inflammatory drugs: chemoreactome analysis

Por I. Yu. Torshin, O. A. Gromova, T. R. Grishina, V. A. Semenov
Publicado em 2020-10-01

Pharmacokinetic and bioequivalence study comparing a fimasartan/rosuvastatin fixed-dose combination...

Por Kang, Woo Youl, Seong, Sook Jin, Ohk, Boram, Gwon, Mi-Ri, Kim, Bo Kyung, Cho, Seungil, Shim, Wang-Seob, Lee, Kyung-Tae, Kim, Eun Hee, Yang, Dong Heon, Lee, Hae Won, Yoon, Young-Ran
Publicado no Drug Des Devel Ther (2018)

Novel drugs that target the estrogen-related receptor alpha: their therapeutic potential in breast cancer

Por May FEB
Publicado em 2014-05-01

Transdermal hormone therapy in postmenopausal women: A review of metabolic effects and drug delivery technologies

Por Kopper, Nathan W, Gudeman, Jennifer, Thompson, Daniel J
Publicado em 2009

Determination of the starting dose in the first-in-human clinical trials with monoclonal antibodies...

Por Suh, Hoon Young, Peck, Carl C, Yu, Kyung-Sang, Lee, Howard
Publicado no Drug Des Devel Ther (2016)

Anticancer efficacy and absorption, distribution, metabolism, and toxicity studies of Aspergiolide A in early drug development

Por Wang, Yuanyuan, Qi, Xin, Li, Dehai, Zhu, Tianjiao, Mo, Xiaomei, Li, Jing
Publicado em 2014

Pharmacokinetic and bioequivalence study of a telmisartan/S-amlodipine fixed-dose combination (CKD...

Por Kang, Woo Youl, Seong, Sook Jin, Ohk, Boram, Gwon, Mi-Ri, Kim, Bo Kyung, La, Sookie, Kim, Hyun-Ju, Cho, Seungil, Yoon, Young-Ran, Yang, Dong Heon, Lee, Hae Won
Publicado no Drug Des Devel Ther (2018)

Deposition and transport of linezolid mediated by a synthetic surfactant Synsurf(®) within a pressurized metered dose inhaler: a Calu-3 model

Por van Rensburg, Lyné, van Zyl, Johann M, Smith, Johan
Publicado no Drug Des Devel Ther (2018)

Fixed-dose combination orally disintegrating tablets to treat cardiovascular disease: formulation...

Por Dennison, Thomas J, Smith, Julian C, Badhan, Raj K, Mohammed, Afzal R
Publicado no Drug Des Devel Ther (2017)

Drug delivery options to increase patient adherence and satisfaction in the management of rheumatoid arthritis – focus on subcutaneous tocilizumab

Por Nakashima, Yasuharu, Kondo, Masakazu, Miyahara, Hisaaki, Iwamoto, Yukihide
Publicado em 2014